пятница, 15 апреля 2016 г.

Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo

Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo


's stock had its "underperform" rating restated by research analysts at Wells Fargo in a report issued on Friday, MarketBeat.com reports. Shares of Valeant Pharmaceuticals Intl traded down 0.03% during midday trading on Friday, reaching $32.35.



from Biotech News